Preparation of dexamethasone-based cationic liposome and its application to gene delivery in vitro

Journal of Nanoscience and Nanotechnology

Volumn 11, Issue 2, 2011, Pages 1799-1802

  Kim, Tae Hun ^a   Yu, Gwang Sig ^a   Choi, Hye ^a   Shim, Young Jung ^a   Lee, Minhyung ^b   Choi, Joon Sig ^a  

^a Chungnam National University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

Cationic liposome; Dendrimer; Dexamethasone; Gene transfection

Indexed keywords

CATIONIC LIPOSOMES; DEXAMETHASONES; GEL-RETARDATION ASSAY; GENE CARRIER; GENE DELIVERY; GENE TRANSFECTION; IN-VITRO; LIPOFECTAMINE; PAMAM DENDRIMER; PHYSICOCHEMICAL CHARACTERISTICS; POTENTIAL VALUES;

DENDRIMERS; GENE THERAPY; LIPOSOMES; ORGANIC POLYMERS;

GENE TRANSFER;

1,2 DIOLEOYL GLYCERO 3 PHOSPHATIDYL ETHANOLAMINE; 1,2-DIOLEOYL-GLYCERO-3-PHOSPHATIDYL ETHANOLAMINE; CATION; DENDRIMER; DEXAMETHASONE; DRUG CARRIER; LIPOSOME; PAMAM STARBURST; PHOSPHATIDYLETHANOLAMINE;

ARTICLE; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; ISOLATION AND PURIFICATION; METHODOLOGY; NANOTECHNOLOGY; PARTICLE SIZE;

CATIONS; CELL LINE; DENDRIMERS; DEXAMETHASONE; DRUG CARRIERS; HUMANS; LIPOSOMES; NANOTECHNOLOGY; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; TRANSFECTION;

EID: 79954995152     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2011.3407     Document Type: Conference Paper

References (19)

1. V. Vijayanathan, T. Thomas, and T. J. Thomas, Biochemistry 41, 14085 (2002).
2. A. D. Miller, Curr. Top. Microbiol. Immunol. 158, 1 (1992).
3. D. Luo and W. M. Saltzman, Nat. Biotechnol. 18, 33 (2000).
4. M. Lee and S. W. Kim, Pharm. News 9, 407 (2002).
5. M. Breunig, U. Lungwitz, J. Klar, A. Kurtz, T. Blunk, and A. Goepferich, J. Nanosci. Nanotechnol. 4, 512 (2004).
6. J. H. Jeong, S. H. Kim, S. W. Kim, and T. G. Park, J. Nanosci. Nanotechnol. 6, 2790 (2006).
7. M. Nishikawa and L. Huang, Hum Gene Ther. 12, 861 (2001).
8. S. Brunner, T. Sauer, S. Carotta, M. Cotten, M. Saltik, and E. Wagner, Gene Ther. 7, 401 (2000).
9. C. W. Pouton, K. M. Wagstaff, D. M. Roth, G. W. Moseley, and D. A. Jans, Adv. Drug Deliv. Rev. 59, 698 (2007).
10. A. Rebuffat, A. Bernasconi, M. Ceppi, H. Wehrli, S. B. Verca, M. Ibrahim, B. M. Frey, F. J. Frey, and S. Rusconi, Nat Biotechnol. 19, 1155 (2001).
11. I. M. Adcock and G. Caramori, Immunol. Cell Biol. 79, 376 (2001).
12. L. Pujols, J. Mullol, J. Roca-Ferrer, A. Torrego, A. Xaubet, J. A. Cidlowski, and C. Picado, Am. J. Physiol. Cell Physiol. 283, C1324 (2002).
13. V. Shahin, L. Albermann, H. Schillers, L. Kastrup, C. Schafer, Y. Ludwig, C. Stock, and H. Oberleithner, J. Cell Physiol. 202, 591 (2005).
14. A. G. Rebuffat, A. R. Nawrocki, P. E. Nielsen, A. G. Bernasconi, E. Bernal-Mendez, B. M. Frey, and F. J. Frey, FASEB J. 16, 1426 (2002).
15. J. A. Gruneich, A. Price, J. Zhu, and S. L. Diamond, Gene Ther. 11, 668 (2004).
16. J. S. Choi, K. S. Ko, J. S. Park, Y. H. Kim, S. W. Kim, and M. Lee, Int. J. Pharm. 320, 171 (2006).
17. Y. M. Bae, H. Choi, S. Lee, S. H. Kang, Y. T. Kim, K. Nam, J. S. Park, M. Lee, and J. S. Choi, Bioconjug. Chem. 18, 2029 (2007).
18. J. S. Choi, K. Nam, J. Y. Park, J. B. Kim, J. K. Lee, and J. S. Park, J. Controlled Release 99, 445 (2004).
19. T. Mosmann, J. Immunol. Methods 65, 55 (1983).